Daily ReportSep 30, 2026
Anesthesiology, September 30 edition
We read 38 papers and selected 3.
Summary
Today’s most impactful studies advanced mechanistic understanding of anesthetic-induced brain states and developmental neurotoxicity. Cross-species neural profiling identified a conserved anesthetic endpoint, while human brain assembloids and neonatal mouse experiments independently revealed cortical circuit and epigenetic-extracellular matrix mechanisms that may inform safer anesthetic strategies.
Research Themes
- Conserved neural dynamics of anesthesia across species
- Human in vitro modeling of anesthetic brain states
- Mechanisms and therapeutic targets of developmental anesthetic neurotoxicity
Selected Articles
1. Comprehensive profiling of brain dynamics during anesthesia across phylogeny.
This study assembled multiscale neural recordings from six species and extracted more than 6,000 time-series features to define a conserved neural signature of anesthesia. Across species, anesthesia shortened intrinsic neural timescales and reduced inter-regional synchrony, producing spatiotemporal isolation of local activity; centromedian thalamic stimulation in macaques reversed this profile and restored behavioral responsiveness.
Impact: The work provides an unusually broad cross-species and cross-scale framework for understanding anesthesia as a conserved dynamical brain state rather than a collection of drug-specific effects. The reversal by deep-brain stimulation supplies a mechanistically grounded route toward emergence or consciousness-restoration interventions.
Clinical Implications: The findings may support development of neurophysiological biomarkers for anesthetic depth and recovery, and they provide a rationale for testing targeted thalamic or network-level stimulation in disorders of consciousness and delayed emergence. Clinical translation remains investigational because the stimulation evidence was demonstrated in macaques rather than patients.
Key Findings
- A conserved anesthetic dynamical profile was identified across humans, macaques, marmosets, mice, zebrafish and nematodes.
- Anesthesia shortened intrinsic neural timescales and dampened inter-regional synchrony, consistent with spatiotemporal isolation of local neural activity.
- Deep-brain stimulation of the macaque centromedian thalamus reversed the anesthetic dynamical profile and restored behavioral responsiveness.
Methodological Strengths
- Integration of multiscale neural recordings across six phylogenetically diverse species.
- Combination of large-scale feature extraction, stimulation experiments, transcriptional analysis and biophysical modeling.
Limitations
- The abstract does not establish that all anesthetic agents produce identical dynamics or that the findings apply uniformly across anesthetic states.
- Causal restoration of responsiveness by stimulation was demonstrated in macaques, limiting immediate human clinical generalizability.
Future Directions: Future studies should test whether the conserved dynamical signature predicts anesthetic depth, emergence, delirium or disorders of consciousness in patients, and should define the stimulation parameters and neural circuits that can safely reverse maladaptive anesthetic states.
The behavioral effects of anesthetics are highly conserved across species, hinting at shared and fundamental underlying mechanisms. Here we compile a dataset of multiscale neural activity during wakefulness and anesthesia, encompassing human, macaque, marmoset, mouse, zebrafish and nematode. Applying massive feature extraction, we characterize local neural dynamics across >6,000 time-series features. This reveals a conserved dynamical profile of anesthesia across species, characterized by shorter intrinsic timescales of neural activity and dampened inter-regional synchrony.
2. Neonatal Sevoflurane Exposure Induces Long-Term Cognitive Impairment via Epigenetically Mediated MMP9 Activation and Perineuronal Net Disruption in the Hippocampal CA2.
Repeated neonatal sevoflurane exposure produced persistent hippocampal CA2 perineuronal-net degradation and deficits in object recognition and social discrimination. The proposed mechanism links loss of H3K27me3 at the Mmp9 promoter to MMP9 activation, impaired BDNF/TrkB signaling and synaptic disruption; CA2-targeted Hapln1 overexpression or pharmacological MMP9 inhibition rescued structural, synaptic and behavioral abnormalities.
Impact: This study identifies a previously underappreciated epigenetic-extracellular matrix mechanism for persistent developmental anesthetic neurotoxicity and demonstrates rescue in targeted genetic and pharmacological experiments. It therefore moves beyond association toward a testable therapeutic strategy.
Clinical Implications: The findings highlight MMP9, perineuronal-net integrity and the hippocampal CA2 extracellular matrix as potential targets for preventing or mitigating developmental anesthetic neurotoxicity. Translation to pediatric anesthesia requires confirmation in additional species, clinically relevant exposure conditions and human developmental tissue or biomarkers.
Key Findings
- Repeated 3% sevoflurane exposure during postnatal days 6-8 caused persistent CA2-specific perineuronal-net degradation in adult mice.
- Epigenetic loss of H3K27me3 at the Mmp9 promoter increased MMP9 expression and disrupted BDNF/TrkB signaling, PSD-95 density, dendritic spines and mEPSC frequency.
- CA2-targeted Hapln1 overexpression and MMP9 inhibition restored perineuronal-net integrity, synaptic function and cognitive behaviors.
Methodological Strengths
- Integrated behavioral testing, histological and synaptic analyses, epigenetic assessment, spatial transcriptomics and targeted rescue experiments.
- Demonstrated mechanistic convergence through both genetic manipulation and pharmacological MMP9 inhibition.
Limitations
- The study is based on neonatal mice, and species differences may limit direct extrapolation to human infants.
- The exposure paradigm and developmental timing may not fully represent the dose, duration or clinical context of pediatric anesthesia.
Future Directions: Future work should validate the CA2-MMP9-perineuronal-net pathway in other developmental models, determine whether brief or clinically typical exposures produce similar effects, and identify safe interventions that preserve extracellular matrix integrity without disrupting normal plasticity.
Sevoflurane is one of the most commonly used general anesthetics in pediatric clinical practice worldwide. Although accumulating preclinical evidence indicates that neonatal sevoflurane exposure causes persistent cognitive impairments, the extracellular mechanisms remain unclear. Herein, we focus on perineuronal nets (PNNs), extracellular matrix (ECM) structures that constrain neuronal excitatory plasticity and are highly enriched in the hippocampal CA2, a region critical for social recognition memory. Neonatal mice repeatedly exposed to 3% sevoflurane (2 h/day, P6-P8) exhibited persistent CA2-specific PNN degradation in adulthood.
3. Human brain assembloids as a model of anaesthetic-induced neural dynamics in vitro.
Human induced pluripotent stem cell-derived cortical-ganglionic eminence assembloids containing excitatory and inhibitory neurons reproduced key electrophysiological features of propofol-induced anesthesia. The model enables direct testing of cortical circuit mechanisms and pharmacological modulation in a human-derived system, helping address whether thalamic involvement is necessary for core anesthetic dynamics.
Impact: The study establishes a human-derived, experimentally accessible model for investigating anesthetic neurophysiology while reducing dependence on whole-animal preparations. Demonstrating anesthetic-state features in a minimal cortical circuit challenges models that require thalamic suppression as the primary initiating mechanism.
Clinical Implications: Human assembloids may support screening of anesthetic effects across patient-specific genetic backgrounds, comparison of developmental vulnerability and identification of circuit-selective agents. They are not yet substitutes for in vivo pharmacokinetic, physiological or behavioral studies.
Key Findings
- Human induced pluripotent stem cell-derived cortical-ganglionic eminence assembloids contained functionally relevant excitatory and inhibitory neuronal populations.
- Propofol exposure produced anesthetic-like electrophysiological changes, including alterations in delta activity, Lempel-Ziv complexity and neuronal firing.
- The platform provides a human-derived model for testing whether cortical excitatory-inhibitory circuitry is sufficient to generate key features of anesthetic neural states.
Methodological Strengths
- Use of human induced pluripotent stem cell-derived assembloids with cellular characterization by immunohistochemistry and single-nucleus RNA sequencing.
- Multimodal electrophysiological recording with control organoids and pharmacological control experiments.
Limitations
- Assembloids lack the full vascular, immune, sensory and long-range network context of the intact human brain.
- The abstract provides limited information about exposure-response relationships, maturation variability and the duration of electrophysiological effects.
Future Directions: Future studies should incorporate thalamic or other subcortical components, compare multiple anesthetic agents and concentrations, and use patient-derived assembloids to investigate developmental, genetic and disease-specific differences in anesthetic responses.
BACKGROUND: The mechanisms by which anaesthetics alter neurophysiological states remain poorly understood. Although some hypotheses emphasise thalamic suppression, others propose that cortical (Cx) circuits alone, comprising interconnected excitatory and inhibitory neurones expressing gamma-aminobutyric acid type A (GABA METHODS: We generated human induced pluripotent stem cell-derived Cx-ganglionic eminence (GE) assembloids and characterised their cellular composition using immunohistochemistry and single-nucleus RNA sequencing. We recorded local field potentials and microelectrode array activity from assembloids exposed to 96 μM propofol, analysing changes in extracellular field delta power (0.1-4 Hz) and Lempel-Ziv complexity, and neuronal firing rates.